Contract proteomics services using proprietary mass‑spectrometry workflows for unbiased target identification, mechanism contextualization, expanded plasma proteome biomarker discovery and high‑sensitivity targeted assays. Targets pharmaceutical and diagnostics companies, analyzing tissues, cells and body fluids (e.g., blood plasma, CSF, solid tissues) for diagnostic, prognostic and treatment biomarker development.